STEM-05. IDH-MUTANT GLIOMAS ARISE FROM GLIAL PROGENITOR CELLS HARBORING THE INITIAL DRIVER MUTATION

Abstract Discovering the cell-of-origin harboring the initial driver mutation provides a fundamental basis for understanding tumor evolution and development of new treatments. For isocitrate dehydrogenase (IDH)-mutant gliomas – the most common malignant primary brain tumors in adults under 50 – the cell-of-origin remains poorly understood. Here, using patient brain tissues and genome-edited mice, we identified glial progenitor cells (GPCs), including oligodendrocyte progenitor cells (OPCs), as the glioma-originating cell type harboring the IDH mutation as the initial driver mutation. We conducted comprehensive deep sequencing, including droplet digital PCR and deep panel and amplicon sequencing to 128 tissues from 62 patients (29 IDH-mutant gliomas and 33 IDH-negative controls) comprising tumors, normal cortex or normal subventricular zone (SVZ), and blood. Surprisingly, low-level IDH mutation was found in the normal cortex away from the tumor in 38.5% (10 of 26) of IDH-mutant glioma patients, whereas no IDH mutation was detected in the normal SVZ. Furthermore, by analyzing cell-type–specific mutations, the direction of clonal evolution, the single-cell transcriptome from patient brains and novel mouse model of IDH-mutant glioma arising from mutation-carrying OPCs, we determined that GPCs, including OPCs, harboring the initial driver mutation are responsible for the development and evolution of IDH-mutant gliomas. In summary, our results demonstrate that GPCs containing the IDH mutation are the cells-of-origin harboring the initial driver mutation in IDH-mutant gliomas.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-11-01
DOI
https://doi.org/10.1093/neuonc/noaf201.0313
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

STEM-05. IDH-MUTANT GLIOMAS ARISE FROM GLIAL PROGENITOR CELLS HARBORING THE INITIAL DRIVER MUTATION

Chungyeul Kim, Keon Woo Kim, Jung Won Park, Jong Hee Chang et al.
Neuro-Oncology
Glioma Diagnosis and Treatment
article

STEM-05. IDH-MUTANT GLIOMAS ARISE FROM GLIAL PROGENITOR CELLS HARBORING THE INITIAL DRIVER MUTATION

Chungyeul Kim, Keon Woo Kim, Jung Won Park, Jong Hee Chang, Jihwan Yoo, Young Seok Ju, Seok‐Gu Kang, Andreas von Deimling, Sangjeong Ahn, Stefan Pusch, Jeong Ho Lee, Sunghoon Kim, Se Hoon Kim, Jiehoon Kwak, Ji‐Hyung Park, Chang Hyun Nam, Jin‐Kyoung Shim, Sang Mee Lee, Saehoon Jung
article en

Abstract

Abstract Discovering the cell-of-origin harboring the initial driver mutation provides a fundamental basis for understanding tumor evolution and development of new treatments. For isocitrate dehydrogenase (IDH)-mutant gliomas – the most common malignant primary brain tumors in adults under 50 – the cell-of-origin remains poorly understood. Here, using patient brain tissues and genome-edited mice, we identified glial progenitor cells (GPCs), including oligodendrocyte progenitor cells (OPCs), as the glioma-originating cell type harboring the IDH mutation as the initial driver mutation. We conducted comprehensive deep sequencing, including droplet digital PCR and deep panel and amplicon sequencing to 128 tissues from 62 patients (29 IDH-mutant gliomas and 33 IDH-negative controls) comprising tumors, normal cortex or normal subventricular zone (SVZ), and blood. Surprisingly, low-level IDH mutation was found in the normal cortex away from the tumor in 38.5% (10 of 26) of IDH-mutant glioma patients, whereas no IDH mutation was detected in the normal SVZ. Furthermore, by analyzing cell-type–specific mutations, the direction of clonal evolution, the single-cell transcriptome from patient brains and novel mouse model of IDH-mutant glioma arising from mutation-carrying OPCs, we determined that GPCs, including OPCs, harboring the initial driver mutation are responsible for the development and evolution of IDH-mutant gliomas. In summary, our results demonstrate that GPCs containing the IDH mutation are the cells-of-origin harboring the initial driver mutation in IDH-mutant gliomas.

Neuro-OncologyVol. 27(Supplement_5)
Daejeon University (KR), Korea Advanced Institute of Science and Technology (KR), Yonsei University (KR), Heidelberg University (DE), Severance Hospital (KR), University Hospital Heidelberg (DE), Seoul National University Bundang Hospital (KR), Gangnam Severance Hospital (KR), Korea University (JP)
Openalex Percentile: Top 50%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.